Department of Medicine 5 – Haematology and Oncology

Eine übermäßige Phagozytose von Myelomzellen induziert Pyroptose in Myelom-assoziierten Makrophagen und beeinträchtigt die Wirksamkeit therapeutischer Antikörper (2022) Flamann C, Biedermann A, Mougiakakos D, Bitterer K, Karg K, Bittenbring J, Büttner-Herold M, et al. Conference contribution Increased CD47 expression inhibits phagocytosis of alloreactive donor T cells after allo-HSCT (2022) Flamann C, Matos C, Kreutz M, Shaikh H, Beilhack A, Büttner-Herold M, Lischer C, et al. Conference contribution Complementary Medicine and Nursing in Oncology Development of evidence-based, symptom-related topic guidelines for interprofessional counseling of tumor patients (2022) Kroeger B, Kaschdailewitsch E, Behzad A, Schmitt A, Lohmueller L, Valentini J, Noack B, et al. Conference contribution Extracellular Vesicles of CLL Cells affect T-Cell Activation and promote their Depletion via diverse immunological Checkpoints (2022) Boettcher M, Boettcher-Loschinski R, Gießl A, Schlötzer-Schrehardt U, Bruns H, Mougiakakos D Conference contribution Interprofessionelle Kommunikation uber,Complementary and Integrative Health" (CIH): Entwicklung und Implementierung eines Training-Programms (2022) Behzad A, Stein B, Schmitt A, Lohmuller L, Kroger B, Boltenhagen U, Joos S, et al. Conference contribution Single-cell Transcriptome Analysis and clonal Kinetics in a Patient after CD19.CAR-T Cell Therapy (2022) Lischer C, Eisenhauer N, Aigner M, Jacobs B, Schletter M, Gebhard C, Rehli M, et al. Conference contribution CXCR2 expression on neutrophil granulocytes in peripheral tumor is associated with shorter survival in oral squamous cell carcinoma (2022) Spörl S, Erber R, Gerken M, Wittenberg M, Fischer R, Taxis J, Hartmann A, et al. Conference contribution Targeted Inhibition of Protein Biosynthesis sensitizes Cancer Cells to IRE1a-mediated Apoptosis as a Consequence of the unfolded protein response (2022) Gsottberger F, Meier C, Ammon AM, Parker S, Wendland K, George R, Petkovic S, et al. Conference contribution Drug Therapy Safety with new oral Antitumor Agents for the Therapy of Prostate and Renal Cell Carcinoma: Findings from the AMBORA Study (2022) Cuba L, Schlichtig K, Dürr P, Bellut L, Meidenbauer N, Kunath F, Goebell P, et al. Conference contribution Immunometabolic alteration in NK cells from multiple myeloma patients (2022) Jacobs B, Richter S, Stoll A, Völkl S, Mackensen A, Mougiakakos D Conference contribution